Suregraft 0.25mg Tablet
Item requires a valid prescription
Manufactured By HOSPIMAX HEALTHCARE PVT LTD
Composition EVEROLIMUS
Rs 438.00
MRP Rs 547.80
(20% OFF)
Includes all taxes
Package SIZE
( 10 TABLET(s) IN A STRIP )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description: Suregraft 0.25mg Tablet is an antineoplastic drug belonging to the class of mTOR inhibitors, containing the active ingredient everolimus. It is used to treat advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumours, and also in the treatment of subependymal giant cell astrocytoma(tumours are found in the ventricles of the brain). Good oral hygiene and regular dental check-ups is important during the treatment since this medicine can cause sores or ulcers in the mouth.
It is often combined with cyclophosphamide, an alkylating agent, to treat subependymal giant cell astrocytoma. Before taking this medicine, it is necessary to know that your risk of getting bacterial or viral infection increases with this treatment. If you have been infected with Hepatitis B, Suregraft 0.25mg Tablet increases the chances of reinfection. Tell your healthcare provider if you experience fever, chills, cough, yellowing of skin, joint pain or swelling during this treatment. You must limit your exposure to sunlight and UV light by wearing protective clothing and applying sunscreen frequently, as this medicine may increase the risk of developing cancers. Avoid taking grapefruit juice or grapefruit while taking this medicine.
Suregraft 0.25mg Tablet are not recommended for adolescents and children under the age of 18. Contact your doctor immediately if you experience shortness of breath, chest pain or worsening cough. During the Suregraft 0.25mg Tablet treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes and kidney parameters to prevent serious complications. This medicine has the potential to cause kidney problems. Report to your doctor if you have been diagnosed with liver disorders, heart failure, high blood cholesterol levels, or hypertension before starting this treatment. Avoid live vaccines and close contact with those who have received live vaccines.
Uses / Indications: • Advanced breast cancer • Advanced renal cell carcinoma • Advanced pancreatic neuroendocrine tumours • Treatment of subependymal giant cell astrocytoma
- Product composition:
- EVEROLIMUS
Interactions / Warnings: • Store Suregraft 0.25mg Tablet in the original package at room temperature (20°C to 25°C).
• Do not freeze.
• Keep it out of reach from children.
- Pregnancy interaction:
- Pregnancy (unsafe): Suregraft 0.25mg Tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
- Expert advice:
- Suregraft 0.25mg Tablet have the tendency to cause harm to unborn foetus. Inform your healthcare provider before starting this treatment if you are pregnant, or have a partner who can become pregnant. Your health care provider will conduct a pregnancy test before you start treatment with Suregraft 0.25mg Tablet. Discuss effective birth control methods with your healthcare provider and use them during treatment and for 8 weeks after your last dose. It is not known if Suregraft 0.25mg Tablet passes into the breast milk. Hence, it is not recommended to breastfeed during this treatment. Occurrence of mouth ulcers or sores are pretty common during this treatment, so your healthcare provider will prescribe a mouthwash. Use the mouthwash as recommended which helps prevent and manage the symptoms.
- Side Effects:
- Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious: • Difficulty breathing, or swallowing • Swelling of face, lips, tongue, throat • Severe itching, red rash, raised bumps Common: • Infection (chills, increased temperature) • Coughing • Wheezing • Excessive thirst • High urine output or severely decreased urine output • Tiredness • Bleeding • Increased appetite with weight loss
- How to use:
- Your doctor will decide the dose and duration of Suregraft 0.25mg Tablet based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Take the tablet at the same time everyday, with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water. If you forgot to take the tablet, simply take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.
- How it works:
- It contains the active ingredient Suregraft 0.25mg Tablet, which inhibits the activity of a protein called mammalian target of rapamycin (mTOR), which regulates cell growth. This drug can slow the growth of abnormal cancer cells by blocking the mTOR protein. Suregraft 0.25mg Tablet helps to reduce the size of tumours and improve outcomes in patients.
- Faq for medicine:
- Q: What you should know before taking Suregraft 0.25mg Tablet? A: Before taking Suregraft 0.25mg Tablet, it is important to know that your risk of getting bacterial or viral infection increases with this treatment. If you have been infected with Hepatitis B, Suregraft 0.25mg Tablet increases the chances of reinfection. Tell your healthcare provider if you experience fever, chills, cough, yellowing of skin, joint pain or swelling during this treatment. Q: Is it safe to use Suregraft 0.25mg Tablet during pregnancy? A: Suregraft 0.25mg Tablet have the tendency to cause harm to unborn fetus. Inform your healthcare provider before starting this treatment if you are pregnant, or have a partner who can become pregnant. Your health care provider will conduct a pregnancy test before you start treatment with Suregraft 0.25mg Tablet. Q: What are the side effects of Suregraft 0.25mg Tablet? A: The common side effects that are likely to occur while you are on the treatment with Suregraft 0.25mg Tablet are fever, chills, skin Rash, joint pain, swelling, tiredness, loss of appetite, high risk of infection, mouth ulcers, difficulty breathing. Q: Is it safe to undergo surgery while on treatment with Suregraft 0.25mg Tablet? A: Suregraft 0.25mg Tablet may lead to poor wound healing ability. Therefore, it is advisable to tell your physician if you plan to have any surgery before starting or during treatment with Suregraft 0.25mg Tablet. Consult your healthcare provider and stop taking Suregraft 0.25mg Tablet at least one week before planned surgery. Q: Can I drink alcohol while taking Suregraft 0.25mg Tablet? A: It is generally recommended to avoid drinking alcohol while taking Suregraft 0.25mg Tablet, as alcohol can increase the risk of liver damage.
- Medicine interaction:
- Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Suregraft 0.25mg Tablet and reduce effectiveness by causing undesirable side effects.
